Your browser doesn't support javascript.
Potential COVID -19 therapeutics in clinical trials - a brief review
Journal of Experimental Biology and Agricultural Sciences ; 10(4):737-742, 2022.
Article in English | CAB Abstracts | ID: covidwho-2040524
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS - CoV2), the causative viral pathogen of the COVID-19 pandemic belongs to the family of Coronaviruses which are positive single stranded RNA viruses. The scientific fraternity has developed and developing various types of vaccines for prevention against COVID-19, such as inactivated virus vaccines, mRNA vaccines, replicating vector protein subunit vaccines, etc., Out of which ten vaccines namely Novovax, Covovax (protein subunit vaccines), Pfizer BNT16b2, Moderna mRNA 1273 (mRNA vaccines), Johnson & Johnson Ad26, Cov2.S, Astrazeneca AZD1222, Covishield (non-replicating viral vector vaccines), Covaxin, Sinopharm BBIBP-CorV, CoronoVac (inactivated vaccines) have been approved for clinical use by WHO. There is an urgent need for SARS-CoV2 specific therapeutics for the treatment of COVID-19 as there is the emergence of various variants such as Alpha, Beta, Gamma, Delta, Omicron, etc. The emergence of variants that possesses immune evading property and spike protein mutation have increased infectivity and more pathogenicity which impelled the need to develop various therapeutics for the treatment of COVID-19. This review compiles the information about potential antiviral candidates in preclinical trials intended for the treatment of COVID-19. The clinical development of such antivirals will be very crucial for the treatment of COVID-19 and also to curb the spread as the present scenario depends on the development of effective prophylactic vaccines.
Keywords

Full text: Available Collection: Databases of international organizations Database: CAB Abstracts Type of study: Prognostic study Language: English Journal: Journal of Experimental Biology and Agricultural Sciences Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: CAB Abstracts Type of study: Prognostic study Language: English Journal: Journal of Experimental Biology and Agricultural Sciences Year: 2022 Document Type: Article